Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

High lead level in respiratory supplement

This article was originally published in The Tan Sheet

Executive Summary

FDA advises consumers not to use Vita Breath herbal supplements, manufactured by American Herbal Lab Inc. of Rosemead, Calif., because tests showed it contains lead at more than 10,000 times the maximum recommended level. New York City health officials notified FDA May 1 after a patient with lead poisoning reported taking Vita Breath and two other herbal products. The NYC officials analyzed a sample of Vita Breath and found it contained 1,100 parts per million of lead. FDA and New York and California officials are investigating Vita Breath, which American Herbal Lab says "supports healthy lung energy and respiratory system." The firm markets 46 products under the new vita brand. FDA's advisory comes after researchers asked the agency to tighten supplement regulation in part to block products with dangerous levels of lead from reaching the market (1"The Tan Sheet" Dec. 7, 2009)

You may also be interested in...



Herbal/Lead Study Calls For Pre-Market Approval, Draws Fire From Industry

A correlation between the use of some herbal supplements and increased blood lead levels in women should prompt tighter FDA regulation of supplements, including requiring pre-market approval, researchers say

Investors Go Beserk For Viking, Putting It Top Of Q1 Winners

The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104090

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel